Listed by the USPTO as MILLER, SERENITY A
Tech Center 3700 • Art Units: 3771 3794
This examiner grants 68% of resolved cases
MILLER, SERENITY A is assigned to tech center 3700 and art unit 3771. Her record includes 124 resolved cases, with an allowance rate of 68.5% and a median of 1091 days to allowance. The interview lift is 36.1%, identifying direct examiner engagement as a potentially important tool for improving outcomes in this record.
The principal companies are Boston Scientific Corporation, Olympus Corporation, and Covidien L.P. The listed firms are SCHWEGMAN LUNDBERG & WOESSNER, P.A., SEAGER, TUFTE & WICKHEM, LLP, and Seager Tufte Wickhem LLP (8150). Practitioners should prepare focused interviews that complement written claim amendments and account for the recorded timeline.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17992978 | ENERGY-BASED SURGICAL INSTRUMENTS AND SYSTEMS CONFIGURED TO MINIMIZE THERMAL SPREAD | Non-Final OA | Covidien LP |
| 19047045 | ANNULOPLASTY MANUAL INTERNAL GUIDEWIRE NAVIGATION | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 18962509 | ELASTIC BAND LIGATION DEVICE | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18962498 | DISTALLY GENERATED ULTRASONIC MOTION RESECTION TOOL | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18586976 | DEVICES, SYSTEMS, AND METHODS FOR ACCESS AND FLUID CIRCULATION WITHIN A BODY | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 18236596 | LITHOTRIPSY CATHETERS | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 18415073 | SURGICAL INSTRUMENT WITH INTEGRATED TISSUE STOP | Final Rejection | Cilag GmbH International |
| 18129639 | System and Method for Clinical Soil Control for a Skin Grafting System | Final Rejection | Medline Industries, LP |
| 19087777 | PURSE-STRING SUTURES | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 18404347 | TREATMENT METHOD AND TREATMENT SYSTEM | Final Rejection | OLYMPUS MEDICAL SYSTEMS CORP. |
| 18176030 | ULTRASONIC TREATMENT TOOL | Non-Final OA | Olympus Corporation |
| 17634676 | POLYURETHANE-REINFORCED HYDROGEL CARDIAC PATCH | Non-Final OA | The Regents of the University of Colorado, a Body Corporate |
| 18287491 | MINIMALLY INVASIVE APPENDECTOMY DEVICE AND METHOD | Non-Final OA | Wake Forest University Health Sciences |
| 18786865 | FORCEPS INCLUDING ROTATIONALLY LOCKED SHAFTS | Final Rejection | GYRUS ACMI, INC. D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA |
| 17661669 | TISSUE-REMOVING CATHETER WITH GUIDEWIRE ISOLATION LINER | Final Rejection | Medtronic Vascular, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy68.5% of resolved applications examined by Serenity A Miller were allowed (124 resolved cases), compared with 65.9% across Art Unit 3771 over the last five years.
This examiner's interview lift is +36.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Serenity A Miller took 1,091 days on average from filing to allowance.
Serenity A Miller examines applications in Art Unit 3771 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
